my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
CellGenix is a leading global supplier of high quality reagents and tools in the expanding markets of cell and gene therapy and regenerative medicine. CellGenix’ product portfolio includes growth factors, cytokines, serum-free media as well as closed cell culture systems (EU only). The products are more
As a global leader in R&D genomics services, GENEWIZ leads the way in providing superior data quality with unparalleled technical support to enable researchers around the world to advance their scientific discoveries faster than ever before. Our customers at top-tier pharmaceutical, biotechnology, more
For over 30 years, Miltenyi Biotec has been a major provider of products and services that drive biomedical research and boost cell and gene therapy. More than 3,500 employees in 28 countries combine excellence in research with innovative products to create cutting-edge solutions that make cancer an more
With effect from 20.01.2023, CO.DON's business activities will be continued in the legal form of a GmbH (limited liability company) following a transferring reorganisation. The asset deal with Rejuvenate GmbH, a company of the American-Chinese ReLive Group, concluded in October 2022 as a result of a more
Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, investigators have developed a new cell therapy approac more
A Munich student team won a Gold Medal in the world's largest academic competition for the field of Synthetic Biology with their project aimed at improving cell therapies against cancer. The group from the Technical University of Munich (TUM) and Ludwig Maximilian University of Munich (LMU) was the more
Watchlist
This is where you can add this topic to your personal favourites
© 1997-2023 LUMITOS AG, All rights reserved
Topics
